These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1880068)

  • 1. Inactivation of fusidic acid by resistant Streptomyces strains.
    von der Haar B; Rosenberg D; Dittrich W; Schrempf H
    J Antibiot (Tokyo); 1991 Jul; 44(7):785-92. PubMed ID: 1880068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a novel extracellular Streptomyces lividans 66 enzyme inactivating fusidic acid.
    von der Haar B; Schrempf H
    J Bacteriol; 1995 Jan; 177(1):152-5. PubMed ID: 8002612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of fusidic acid by pathogenic Nocardia.
    Harada K; Tomita K; Fujii K; Sato N; Uchida H; Yazawa K; Mikami Y
    J Antibiot (Tokyo); 1999 Mar; 52(3):335-9. PubMed ID: 10348053
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel fusidic acid resistance gene from Streptomyces lividans 66 encodes a highly specific esterase.
    von der Haar B; Walter S; Schwäpenheer S; Schrempf H
    Microbiology (Reading); 1997 Mar; 143 ( Pt 3)():867-874. PubMed ID: 9084170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial Oxidation of the Fusidic Acid Side Chain by
    Ibrahim AS; Elokely KM; Ferreira D; Ragab AE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29690500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antibacterial hydroxy fusidic acid analogue from Acremonium crotocinigenum.
    Evans L; Hedger JN; Brayford D; Stavri M; Smith E; O'Donnell G; Gray AI; Griffith GW; Gibbons S
    Phytochemistry; 2006 Oct; 67(19):2110-4. PubMed ID: 16930645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial O-carbamylation of novobiocin.
    Kuo MS; Yurek DA; Chirby DG; Cialdella JI; Marshall VP
    J Antibiot (Tokyo); 1991 Oct; 44(10):1096-100. PubMed ID: 1955392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helvolic Acid Derivatives with Antibacterial Activities against Streptococcus agalactiae from the Marine-Derived Fungus Aspergillus fumigatus HNMF0047.
    Kong FD; Huang XL; Ma QY; Xie QY; Wang P; Chen PW; Zhou LM; Yuan JZ; Dai HF; Luo DQ; Zhao YX
    J Nat Prod; 2018 Aug; 81(8):1869-1876. PubMed ID: 30070829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies of antibiotic sensitivities of Streptomyces somaliensis--a cause of human actinomycetoma.
    Nasher MA; Hay RJ; Mahgoub ES; Gumaa SA
    Trans R Soc Trop Med Hyg; 1989; 83(2):265-8. PubMed ID: 2609384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid.
    O'Neill AJ; Bostock JM; Moita AM; Chopra I
    J Antimicrob Chemother; 2002 Dec; 50(6):839-48. PubMed ID: 12461002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fragmentation characteristics of the polyether antibiotic complex isolated from Streptomyces hygroscopicus strains IM-110-81 and IM-111-81 (DIKLS) in mass spectrometry].
    Rachev R; Ivanova V; Sakhanekova M; Schlegel R; Kleinwächter W
    Acta Microbiol Bulg; 1985; 16():11-21. PubMed ID: 4036666
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of novel derivative of helvolic acid from Metarhizium anisopliae grown in medium with insect component.
    Lee SY; Kinoshita H; Ihara F; Igarashi Y; Nihira T
    J Biosci Bioeng; 2008 May; 105(5):476-80. PubMed ID: 18558337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new helvolic acid derivative from an endophytic Fusarium sp. of Ficus carica.
    Liang XA; Ma YM; Zhang HC; Liu R
    Nat Prod Res; 2016 Nov; 30(21):2407-12. PubMed ID: 27265219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction of antibiotic formation by inactive cultures of actinomycetes. A mutant strain of Streptomyces helvaticus, a new producer of bruneomycin].
    Malkina ND; Dudnik IuV; Lysenkova LN; Terekhova LP; Katrukha GS
    Antibiot Khimioter; 1995 Jun; 40(6):3-6. PubMed ID: 8593091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of resistance to fusidic acid in Staphylococcus aureus.
    Chopra I
    J Gen Microbiol; 1976 Oct; 96(2):229-38. PubMed ID: 993776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy of antibiotics against Streptomyces somaliensis isolates in vitro.
    Nasher MA; Hay RJ
    J Antimicrob Chemother; 1998 Feb; 41(2):281-4. PubMed ID: 9533473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergistic antibacterial activities of helvolic acid on multi-drug resistant Staphylococcus aureus.
    Qin L; Li B; Guan J; Zhang G
    Nat Prod Res; 2009; 23(4):309-18. PubMed ID: 19296371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusidane antibiotics produced by dermatophytes.
    Perry MJ; Hendricks-Gittins A; Stacey LM; Adlard MW; Noble WC
    J Antibiot (Tokyo); 1983 Dec; 36(12):1659-63. PubMed ID: 6662806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essramycin: a first triazolopyrimidine antibiotic isolated from nature.
    El-Gendy MM; Shaaban M; Shaaban KA; El-Bondkly AM; Laatsch H
    J Antibiot (Tokyo); 2008 Mar; 61(3):149-57. PubMed ID: 18503193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rubomycin Q1--an anthracycline metabolite from Streptomyces coeruleorubidus 2679, a strain producing rubomycin C].
    Fedorova GB; Golova TP; Arkhangel'skaia NM; Lazhko EI; Abramova EA; Bychkova OP; Polunin AD; Katrukha GS
    Antibiot Khimioter; 1996 Mar; 41(3):3-8. PubMed ID: 8967800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.